Alnylam Pharmaceuticals
ALNY
#625
Rank
โ‚ฌ27.08 B
Marketcap
209,24ย โ‚ฌ
Share price
5.08%
Change (1 day)
47.57%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company